Market
Boston Scientific expects headcount reductions amid restructuring initiative
Boston Scientific announced a restructuring initiative expected to result in headcount reductions, with total costs estimated between $700 million and $800 million through the end of 2029. The company did not disclose the specific number of positions affected or operational details in the announcement.
The source
This brief is a MedIndexer summary of reporting by Medical Device Network. To read the full story, head to the source.
Read the full story at Medical Device Network